Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

NK cells play a role in skin diseases like eczema and psoriasis.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

PDGF signaling may play a role in hair growth cycle regulation.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.